Novavax signs COVID-19 vaccine supply deal with India’s Serum Institute

The deal will foster development and commercialisation of COVID-19 vaccine

The Indian drugmaker will have exclusive rights for the vaccine in India

The experimental vaccine is said to produce high levels of antibodies against COVID-19

Share.

Comments are closed.

Get to know the
Exclusively Curated by Channeliam
Top Startups
channeliam.com
Get to know the
Exclusively Curated by Channeliam
Top Startups
channeliam.com
Exit mobile version